Leukemia (journal): Difference between revisions
CSV import |
No edit summary |
||
| Line 29: | Line 29: | ||
[[Category:Nature Research academic journals]] | [[Category:Nature Research academic journals]] | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:Leukemia_cover.gif|Leukemia (journal) | File:Leukemia_cover.gif|Leukemia (journal) | ||
</gallery> | </gallery> | ||
Latest revision as of 00:34, 17 March 2025
Leukemia is a peer-reviewed medical journal covering research in oncology, specifically in the area of leukemia. The journal was established in 1987 and is published by the Nature Publishing Group. The editor-in-chief is Robert Peter Gale (Imperial College London). According to the Journal Citation Reports, the journal has a 2019 impact factor of 10.023.
History[edit]
The journal Leukemia was established in 1987. It is published by the Nature Publishing Group, a division of Springer Nature, which is known for publishing high-impact scientific and medical literature.
Scope[edit]
Leukemia covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, cell cycle, signal transduction, molecular genetics, and clinical research.
Editorial Board[edit]
The editor-in-chief of Leukemia is Robert Peter Gale, a physician, medical researcher, and author who is currently based at Imperial College London. He is known for his work in leukemia and other hematological disorders.
Impact Factor[edit]
According to the Journal Citation Reports, the journal has a 2019 impact factor of 10.023. This measure reflects the yearly average number of citations to recent articles published in the journal.
See Also[edit]
References[edit]
<references />
